Prevention, Classification and Management Review of Deep Sternal Wound Infection
Keywords:sternotomy, Surgical wound infection, Sternum, mediastinitis
Sternal wound complications are significant problems in cardiac surgery and cause challenges to surgeons as they are associated with high mortality, morbidity, and a tremendous load on the hospital budget. Risk factors and preventive measures against sternal wound infection need to be in focus. Classification of different types of sternotomy complications post cardiac surgery is important for specific categorization and management. Reviewing the literature, a variety of classifications was introduced to help understand the pathophysiology of these wounds and how best to manage them. Initial classifications were based on the postoperative period of the infectious process and risk factors. Recently, the anatomical description of sternal wound, including the depth and location, was shown to be more practical. There is a lack of evidence-based surgical consensus for the appropriate management strategy, including type of closure, choice of sternal coverage post sternectomy, whether primary, delayed and when to use reconstructive flaps.
Abu-Omar Y, Kocher GJ, Bosco P, et al. 2017. European association for cardio-thoracic surgery expert consensus statement on the prevention and management of mediastinitis. Eur J Cardiothorac Surg. 51(1):10–29.
Al-Ebrahim K. 2003. Reinforced sternal closure; the bilateral straight longitudinal wire technique. Asian Cardiovasc Thorac Ann. 11: 90–91.
Al-Ebrahim K, Shafei H. 1996. A new technique for reinforced sternal closure. Asian Cardiovasc Thorac Ann 4: 117–8.
Al-Ebrahim KE. 2009. Sternocutaneous fistula after cardiac surgery. Ann Thorac Surg 88:1910-5.
Al-Ebrahim, KE. 2020. Management of Deep Sternal Wound Infection: Complete Sternal Osteomyelitis. The Heart Surgery Forum 23(3), E281-E284.
Anger J, Dantas D, Arnoni R, Farsky P. 2015. A new classification of post-sternotomy dehiscence. Rev Bras Cir Cardiovasc. 30(1): 114–118.
Anger J, Farsky PS, Almeida AF, Arnoni RT, Dantas DC. 2012. Use of the pectoralis major fasciocutaneous flap in the treatment of post sternotomy dehiscence: a new approach. Einstein. 10(4):449–454.
Berdajs DA, Trampuz A, Ferrari E, Ruchat P, Hurni M, von Segesser LK. 2011. Delayed primary versus late secondary wound closure in the treatment of postsurgical sternum osteomyelitis. Interact Cardiovasc Thorac Surg. 12(6):914–918.
Botianu PVH. 2019. Current indications for the intrathoracic transposition of the omentum. J Cardiothorac Surg. 14(1):103.
Cutrell JB, Barros N, McBroom M, et al. 2016. Risk factors for deep sternal wound infection after cardiac surgery: influence of red blood cell transfusions and chronic infection. Am J Infect Control. 44(11):1302–1309.
Dalton ML, Connally SR, Sealy WC. 1992. Julian’s reintroduction of Milton’s operation. Ann Thorac Surg. 53:532–3.
Davison SP, Clemens MW, Armstrong D, Newton ED, Swartz W. 2007. Sternotomy wounds: rectus flap versus modified pectoral reconstruction. Plast Reconstr Surg. Sep 15. 120(4):929-34.
Debreneci T, Szerafin T, Galajda Z, Miskolczi S, Peterfly A. 2008. Results of vacuum-assisted wound closure system in the treatment of sternotomy wound infections following cardiac surgery. Magyar Sebeszet. 61:10.1556.
Dickie SR, Dorafshar AH, Song DH. 2006. Definitive closure of the infected median sternotomy wound: a treatment algorithm utilizing vacuum-assisted closure followed by rigid plate fixation. Ann Plast Surg. Jun. 56(6):680-5.
El Oakley RM, Wright JE. 1996. Postoperative mediastinitis: classification and management. Ann Thorac Surg. 61(3):1030–1036.
Elassal AA, Al-Ebrahim KE, Al-Radi OO, Jabbad HH, Eldib OS. 2020. Sternal Wound Complications: Objective Reclassification and Surgical Reconsideration. The Heart Surgery Forum 23(1), E076-E080.
Farsky PS, Graner H, Duccini P, Zandonadi Eda C, Amato VL, Anger J, et al. 2011. Risk factors for sternal wound infections and application of the STS score in coronary artery bypass graft surgery. Rev Bras Cir Cardiovasc. 26(4):624–629.
Fawzy H, Osei-Tutu K, Errett L, Latter D, Bonneau D, Musgrave M, et al. 2011. Sternal plate fixation for sternal wound reconstruction: initial experience (retrospective study). J Cardiothorac Surg. Apr 29. 6:63.
Greig AV, Geh JL, Khanduja V, Shibu M. 2007. Choice of flap for the management of deep sternal wound infection--an anatomical classification. J Plast Reconstr Aesthet Surg 60(4):372–378.
Jones G, Jurkiewicz MJ, Bostwick J, Wood R, Bried JT, Culbertson J, et al. 1997. Management of the infected median sternotomy wound with muscle flaps. The Emory 20-year experience. Ann Surg. 225(6):766.
Khanlari B, Elzi L, Estermann L, et al. 2010. A rifampicin-containing antibiotic treatment improves outcome of staphylococcal deep sternal wound infections. J Antimicrob Chemother. 65(8):1799–1806.
Kubota H, Miyata H, Motomura N, et al. 2013. Deep sternal wound infection after cardiac surgery. J Cardiothorac Surg. 8(1):132.
Lazar HL, Salm TV, Engelman R, Orgill D, Gordon S. 2016. Prevention and management of sternal wound infections. Thorac Cardiovasc Surg. 152(4):962-972.
Öztürk S, Öztürk I, İlhan S. 2015. Kalp cerrahisinde ameliyat sonrası mediastinitle ilişkili risk etkenleri: Sistematik derleme ve meta analiz. Turk Gogus Kalp Dama. Turk Gogus Kalp Dama 23(2):401-412.
Pairolero PC, Arnold PG. 1984. Management of recalcitrant median sternotomy wounds. J Thorac Cardiovasc Surg. 88(3):357–364.
Robicsek F, Fokin A, Cook J, Bhatia D. 2000. Sternal instability after midline sternotomy. Thorac Cardiovasc Surg. 48:1–8.
Rupprecht L, Schmid C. 2013. Deep sternal wound complications: an overview of old and new therapeutic options. Open J Cardiovasc Surg. 6:9–19.
Salehi Omran A, Karimi A, Ahmadi SH, et al. 2007. Superficial and deep sternal wound infection after more than 9000 coronary artery bypass graft (CABG): incidence, risk factors and mortality. BMC Infect Dis. 7(1):112.
Schiraldi L, Jabbour G, Centofanti P, et al. 2019. Deep sternal wound infections: Evidence for prevention, treatment, and reconstructive surgery. Arch Plast Surg. 46(4):291–302.
Sears ED, Wu L, Waljee JF, Momoh AO, Zhong L, Chung KC. 2016. The impact of deep sternal wound infection on mortality and resource utilization: a population-based study. World J Surg. 40(11):2673–2680.
Singh K, Anderson E, Harper JG. 2011. Overview and management of sternal wound infection. Semin Plast Surg. 25:25–33.
Tewarie L, Moza AK, Khattab MA, Autschbach R, Zayat R. 2019. Effective Combination of Different Surgical Strategies for Deep Sternal Wound Infection and Mediastinitis. Ann Thorac Cardiovasc Surg. 25(2):102–110.
van Wingerden JJ, Lapid O, Boonstra PW, de Mol BA. 2011. Muscle flaps or omental flap in the management of deep sternal wound infection. Interact Cardiovasc Thorac Surg. 13:179–87.
van Wingerden JJ, Ubbink DT, van der Horst CM, et al. 2014. Poststernotomy mediastinitis: a classification to initiate and evaluate reconstructive management based on evidence from a structured review. J Cardiothorac Surg. 9:179.
Weinand C, Phan TQV, Perbix W, et al. 2013. A reconstructive algorithm for deep sternal wound coverage: the Cologne-Merheim approach. Eur J Plast Surg. 36:95–104.
Yusuf E, Chan M, Renz N, Tranpuz A. 2018. Current perspectives on diagnosis and management of sternal wound infections. Infect Drug Resist. Jul 16;11:961-968.
Zahiri HR, Lumpkins K, Kelishadi SS, Zhu Y, Medina D, Condé-Green A, et al. 2012. Significant Predictors of Complications After Sternal Wound Reconstruction: A 21-Year Experience. Ann Plast Surg. 69(4):439-41.
How to Cite
Author Disclosure & Copyright Transfer Agreement
In order to publish the original work of another person(s), The Heart Surgery Forum® must receive an acknowledgment of the Author Agreement and Copyright Transfer Statement transferring to Forum Multimedia Publishing, L.L.C., a subsidiary of Carden Jennings Publishing Co., Ltd. the exclusive rights to print and distribute the author(s) work in all media forms. Failure to check Copyright Transfer agreement box below will delay publication of the manuscript.
A current form follows:
The author(s) hereby transfer(s), assign(s), or otherwise convey(s) all copyright ownership of the manuscript submitted to Forum Multimedia Publishing, LLC (Publisher). The copyright transfer covers the exclusive rights to reproduce and distribute the article and the material contained therein throughout the world in all languages and in all media of expression now known or later developed, including but not limited to reprints, photographic reproduction, microfilm, electronic data processing (including programming, storage, and transmission to other electronic data record(s), or any other reproductions of similar nature), and translations.
However, Publisher grants back to the author(s) the following:
- The right to make and distribute copies of all or part of this work for use of the author(s) in teaching;
- The right to use, after publication in The Heart Surgery Forum, all or part of the material from this work in a book by the author(s), or in a collection of work by the author(s);
- The royalty-free right to make copies of this work for internal distribution within the institution/company that employs the author(s) subject to the provisions below for a work-made-for-hire;
- The right to use figures and tables from this work, and up to 250 words of text, for any purpose;
- The right to make oral presentations of material from this work.
Publisher reserves the right to grant or refuse permission to third parties to republish all or part of the article or translations thereof. To republish, such third parties must obtain written permission from the Publisher. (This is in accordance with the Copyright Statute, United States Code, Title 17. Exception: If all authors were bona fide officers or employees of the U.S. Government at the time the paper was prepared, the work is a “work of the US Government” (prepared by an officer or employee of the US Government as part of official duties), and therefore is not subject to US copyright; such exception should be indicated on signature lines. If this work was prepared under US Government contract or grant, the US Government may reproduce, royalty-free, all or portions of this work and may authorize others to do so, for official US Government purposes only, if the US Government contract or grant so requires.
I have participated in the conception and design of this work and in the writing of the manuscript and take public responsibility for it. Neither this manuscript nor one with substantially similar content under my authorship has been published, has been submitted for publication elsewhere, or will be submitted for publication elsewhere while under consideration by The Heart Surgery Forum, except as described in an attachment. I have reviewed this manuscript (original version) and approve its submission. If I am listed above as corresponding author, I will provide all authors with information regarding this manuscript and will obtain their approval before submitting any revision. I attest to the validity, accuracy, and legitimacy of the content of the manuscript and understand that Publisher assumes no responsibility for the validity, accuracy, and legitimacy of its content. I warrant that this manuscript is original with me and that I have full power to make this Agreement. I warrant that it contains no matter that is libelous or otherwise unlawful or that invades individual privacy or infringes any copyright or other proprietary right. I agree to indemnify and hold Publisher harmless of and from any claim made against Publisher that relates to or arises out of the publication of the manuscript and agree that this indemnification shall include payment of all costs and expenses relating to the defense of any such claim, including all reasonable attorney’s fees.
I warrant that I have no financial interest in the drugs, devices, or procedures described in the manuscript (except as disclosed in the attached statement).
I state that the institutional Human Subjects Committee and/or the Ethics Committee approved the clinical protocol reported in this manuscript for the use of experimental techniques, drugs, or devices in human subjects and appropriate informed consent documents were utilized.
Furthermore, I state that any and all animals used for experimental purposes received humane care in USDA registered facilities in compliance with the “Principles of Laboratory Animal Care” formulated by the National Society for Medical Research and the “Guide for the Care and Use of Laboratory Animals” prepared by the Institute of Laboratory Animal Resources and published by the National Institutes of Health (NIH Publication No. 85-23, revised 1985).